Maternal human leukocyte antigen-G polymorphism is not associated with pre-eclampsia in a Chinese Han population

Tissue Antigens

Volumn 68, Issue 4, 2006, Pages 311-316

  Lin, A ^a   Yan, W H ^a   Dai, M Z ^a   Chen, X J ^a   Li, B L ^a   Chen, B G ^a   Fan, L A ^b  

^a TAIZHOU HOSPITAL OF ZHEJIANG PROVINCE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

HLA G; Polymorphism; Pre eclampsia; Pregnancy

Indexed keywords

HLA G ANTIGEN; MATERNAL ANTIGEN; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ADULT; ARTICLE; BASE MISPAIRING; CHINESE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; ETHNIC DIFFERENCE; EXON; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC REGULATION; GENOTYPE; HUMAN; HUMAN TISSUE; IMMUNOPATHOGENESIS; PLACENTA; POPULATION GENETICS; PREECLAMPSIA; PRIMIPARA; PRIORITY JOURNAL;

ALLELES; CHINA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; MATERNAL-FETAL EXCHANGE; POLYMORPHISM, GENETIC; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY PROTEINS;

EID: 33749562367     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2006.00667.x     Document Type: Article

References (38)

1. Hayward C, Livingstone J, Holloway S, Liston WA, Brock DJ. An exclusion map for pre-eclampsia: assuming autosomal recessive inheritance. Am J Hum Genet 1992: 50: 749-57.
2. Harrison GA, Humphrey KE, Jones N et al. A genome wide linkage study of preeclampsia/eclampsia reveals evidence for a candidate region on 4q. Am J Hum Genet 1997: 60: 1158-67.
3. Takakuwa K, Honda K, Ishii K, Hataya I, Yasuda M, Tanaka K. Studies on the HLA-DRB1 genotypes in Japanese women with severe pre-eclampsia positive and negative for anticardiolipin antibody using a polymerase chain reaction-restriction fragment length polymorphism method. Hum Reprod 1999: 14: 2980-6.
4. de Luca Brunori I, Battini L, Simonelli M et al. Increased HLA-DR homozygosity associated with pre-eclampsia. Hum Reprod 2000: 15: 1807-12.
5. Honda K, Takakuwa K, Hataya I, Yasuda M, Kurabayashi T, Tanaka K. HLA-DQB1 and HLA-DPB1 genotypes in severe preeclampsia. Obstet Gynecol 2000: 96: 385-9.
6. Hiby SE, Walker JJ, O'shaughnessy KM, Redman CWG, Carrington M. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med 2004: 200: 957-65.
7. Rouas-Freiss N, Goncalves RM, Menier C, Dausset J, Carosella ED. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci USA 1997: 94: 11520-5.
8. Carosella ED, Moreau P, Le Maoult J, Le Discorde M, Dausset J, Rouas-Freiss N. HLA-G molecules: from maternal-fetal tolerance to tissue acceptance. Adv Immunol 2003: 81: 199-252.
9. Ishitani A, Sageshima N, Lee N et al. Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition. J Immunol 2003: 171: 1376-84.
10. Moreau P, Dausset J, Carosella ED, Rouas-Freiss N. Viewpoint on the functionality of the human leukocyte antigen-G null allele at the fetal-maternal interface. Biol Reprod 2002: 67: 1375-8.
11. Hofmeister V, Weiss EH. HLA-G modulates immune responses by diverse receptor interactions. Semin Cancer Biol 2003: 13: 317-23.
12. Yan WH, Fan LA. Residues Met76 and Gln79 in HLA-G a1 domain involved in KIR2DL4 recognition. Cell Res 2005: 15: 176-82.
13. Colbern GT, Chiang MH, Main EK. Expression of the nonclassic histocompatibility antigen HLA-G by preeclamptic placenta. Am J Obstet Gynecol 1994: 170: 1244-50.
14. Lim KH, Zhou Y, Janatpour M et al. Human cytotrophoblast differentiation/invasion is abnormal in pre-eclampsia. Am J Pathol 1997: 151: 1809-18.
15. Goldman-Wohl DS, Ariel I, Greenfield C et al. Lack of human leukocyte antigen-G expression in extravillous trophoblasts is associated with pre-eclampsia. Mol Hum Reprod 2000: 6: 88-95.
16. Yie SM, Li LH, Li YM, Librach C. HLA-G protein concentrations in maternal serum and placental tissue are decreased in preeclampsia. Am J Obstet Gynecol 2004: 191: 525-9.
17. Yie SM, Taylor RN, Librach C. Low plasma HLA-G protein concentrations in early gestation indicate the development of preeclampsia later in pregnancy. Am J Obstet Gynecol 2005: 193: 204-8.
18. Aldrich CL, Stephenson MD, Karrison T et al. HLA-G genotypes and pregnancy outcome in couples with unexplained recurrent miscarriage. Mol Hum Reprod 2001: 7: 1167-72.
19. Abbas A, Tripathi P, Naik S, Agrawal S. Analysis of human leukocyte antigen (HLA)-G polymorphism in normal women and in women with recurrent spontaneous abortions. Eur J Immunogenet 2004: 31: 275-8.
20. Hviid TV, Hylenius S, Hoegh AM, Kruse C, Christiansen OB. HLA-G polymorphisms in couples with recurrent spontaneous abortions. Tissue Antigens 2002: 60: 122-32.
21. Aldrich C, Verp MS, Walker MA, Ober C. A null mutation in HLA-G is not associated with preeclampsia or intrauterine growth retardation. J Reprod Immunol 2000: 47: 41-8.
22. Humphrey KE, Harrison GA, Cooper DW, Wilton AN, Brennecke SP, Trudinger BJ. HLA-G deletion polymorphism and pre-eclampsia/eclampsia. Br J Obstet Gynaecol 1995: 102: 707-10.
23. Carreiras M, Montagnani S, Layrisse Z. Preeclampsia: a multifactorial disease resulting from the interaction of the feto-maternal HLA genotype and HCMV infection. Am J Reprod Immunol 2002: 48: 176-83.
24. O'Brien M, McCarthy T, Jenkins D et al. Altered HLA-G transcription in pre-eclampsia is associated with allele specific inheritance: possible role of the HLA-G gene in susceptibility to the disease. Cell Mol Life Sci 2001: 58: 1943-9.
25. Hylenius S, Andersen AM, Melbye M, Hviid TV. Association between HLA-G genotype and risk of pre-eclampsia: a case-control study using family triads. Mol Hum Reprod 2004: 10: 237-46.
26. Gómez-Casado E, Martínez-Laso J, Castro MJ et al. Detection of HLA-E and -G DNA alleles for population and disease studies. Cell Mol Life Sci 1999: 56: 356-62.
27. O'Brien M, Dausset J, Carosella ED, Moreau P. Analysis of the role of HLA-G in preeclampsia. Hum Immunol 2000: 61: 1126-31.
28. Avril T, Jarousseau AC, Watier H et al. Trophoblast cell line resistance to NK lysis mainly involves an HLA class independent mechanism. J Immunol 1999: 162: 5902-9.
29. King A, Hiby S, Gardner L et al. Recognition of trophoblast HLA class I molecules by decidual NK cell receptor. Placenta 2000: 21 (Suppl. A): S81-5.
30. Kovats S, Main EK, Librach C, Stubblebine M, Fisher S, DeMars R. A non-classical class I antigen, HLA-G, is expressed in human cytotrophoblasts. Science 1990: 248: 220-3.
31. Bouteiller PL, Solier C, Proll J, Aguerre-Girr M, Fournel S, Lenfant F. Placental HLA-G expression in vivo: where and what for? Hum Reprod Update 1999: 5: 223-33.
32. Pazmany L, Mandelboim O, Vales Gromez M, Davis DM, Reyburn HT, Strominger JL. Protection from natural killer cell-mediated lysis by HLA-G expression on target cells. Science 1996: 274: 792-5.
33. Marchal-Bras-Goncalves R, Rouas-Freiss N, Connan F et al. A soluble HLA-G protein that inhibits natural killer cell-mediated cytotoxicity. Transplant Proc 2001: 33: 2355-9.
34. Harrison GA, Humphrey KE, Jakobsen IB, Cooper DW.A14 bp deletion polymorphism in the HLA-G gene. Hum Mol Genet 1993: 2: 2200.
35. Hviid TV, Hylenius S, Roerbye C, Nielsen LC. HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels. Immunogenetics 2003: 55: 63-79.
36. Bermingham J, Jenkins D, McCarthy T, O'Brien M. Genetic analysis of insulin-like growth factor II and HLA-G in pre-eclampsia. Biochem Soc Trans 2000: 28: 215-9.
37. Hviid TV, Hylenius S, Lindhard A, Christiansen OB. Association between human leukocyte antigen-G genotype and success of in vivo fertilization and pregnancy outcome. Tissue Antigens 2004: 64: 66-9.
38. Tripathi P, Abbas A, Naik S, Agrawal S. Role of 14-bp deletion in the HLA-G gene in the maintenance of pregnancy. Tissue Antigens 2004: 64: 706-10.